Abstract CN99
Background
Chemotherapy-induced peripheral neuropathy (CIPN) remains a significant challenge in cancer treatment, impacting both the quality of life and treatment outcomes of patients. Chemotherapy-induced peripheral neuropathy (CIPN) is a common and often debilitating side effect of many chemotherapy agents, including platinum compounds, taxanes, vinca alkaloids, proteasome inhibitors, immune checkpoint inhibitors, biologic agents and hormonal therapy drugs among others. It presents as a spectrum of sensory, motor, and autonomic symptoms, ranging from tingling and numbness to severe pain and functional impairment.
Methods
We narrative rewied the literature, purpose of to to underline the importance of precise, early and individualized management of CIPN, based on new evidence-based practice protocols and therapies.
Results
Management of CIPN remains complicated and demand a multidisciplinary therapy including cancer nurses, oncologists, neurologists, dietitians and pain specialists. The most common therapy approaches are both pharmacologist and non-pharmacologist interventions. Dose modification using “stop and go” technique is totally necessary for patients with high risk of developing CIPN, resulting in better management of CIPN. Refer to, pharmacological interventions, many studies have shown the need and many benefits using antidepressants (duloxetine, amitriptyline, imipramine, venlafaxine), antiepileptic drugs (gabapentin, pregabalin, phenyntoin), topical agents (lidocaine patches, capsaicine crème, baclofen, amitryptiline, ketamine) and nonsteroidal anti-inflammatory drugs and opioids. Nevertheless, no pharmacologists interventions include complementary and alternative medicine. Also, food supplements such us B12, Magnesium, Calcium and Glutathione would be beneficial for CIPN management.
Conclusions
Interdisciplinary approach is certainly indivisible part of CIPN management. Both, symptoms and supportive individualized care, can result in better outcomes, increasing patients’ overall quality of life. Additionally, integrating expertise cancer nurses into the management of CIPN is a huge challenge for every day clinical practice.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN58 - Canadian resources and strategies to build global oncology nursing excellence
Presenter: Gayatre Maharaj
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN62 - Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset gastric cancer: A retrospective cohort study on 18877 patients
Presenter: Yingxue Liu
Session: EONS Poster Display session
Resources:
Abstract
CN63 - Quality of life among parents of children with cancer
Presenter: Abeer Hussain
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN74 - Exploring the correlation between spiritual health, quality of survival, and meaning of life among breast cancer chemotherapy patients
Presenter: Fang Zhao
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN75 - Telehealth interventions and functional outcomes in breast cancer rehabilitation: A systematic review
Presenter: Marco Invernizzi
Session: EONS Poster Display session
Resources:
Abstract
CN76 - A study of sexual dysfunction in Moroccan female survivors of gynaecological cancer: A prospective study about 220 patients
Presenter: Chadia Ezzouitina
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN77 - ‘Eating with others’: Planning, developing and testing a self-management intervention to promote social eating for patients living with and beyond head and neck cancer
Presenter: Mark Dornan
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN79 - Quality-of-Life (QoL) data published by clinical trials supporting drug approvals for renal cell carcinoma (RCC)
Presenter: Rowanne Seadon
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN80 - Why do some patients undergoing laryngectomy for head and neck cancer opt to not reacquire their voice?
Presenter: Miyoko Iwai
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN81 - How to use a theoretical framework to inform intervention development in a breast cancer study?
Presenter: Sek Ying Chair
Session: EONS Poster Display session
Resources:
Abstract
Slides